1. Home
  2. BENF vs BTMD Comparison

BENF vs BTMD Comparison

Compare BENF & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beneficient

BENF

Beneficient

HOLD

Current Price

$4.68

Market Cap

60.6M

Sector

Finance

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.12

Market Cap

64.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BENF
BTMD
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
64.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BENF
BTMD
Price
$4.68
$2.12
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
516.9K
140.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.68
Revenue
N/A
$197,191,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$93.54
$2.37
P/E Ratio
N/A
$3.18
Revenue Growth
N/A
6.38
52 Week Low
$0.22
$2.02
52 Week High
$9.96
$4.75

Technical Indicators

Market Signals
Indicator
BENF
BTMD
Relative Strength Index (RSI) 53.86 44.88
Support Level $3.99 $2.02
Resistance Level $5.21 $2.37
Average True Range (ATR) 0.58 0.10
MACD 0.07 0.02
Stochastic Oscillator 70.78 44.44

Price Performance

Historical Comparison
BENF
BTMD

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and a financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Share on Social Networks: